Literature DB >> 30573681

Interleukin 34 (IL-34) cell-surface localization regulated by the molecular chaperone 78-kDa glucose-regulated protein facilitates the differentiation of monocytic cells.

Sayaka Ogawa1, Yukiko Matsuoka1, Miho Takada1, Kazue Matsui1, Fumihiro Yamane1, Eri Kubota2, Shiori Yasuhara1, Kentaro Hieda1, Naoki Kanayama1,3, Naoya Hatano3, Hiroshi Tokumitsu1,3, Masaki Magari4,3.   

Abstract

Interleukin 34 (IL-34) constitutes a cytokine that shares a common receptor, colony-stimulating factor-1 receptor (CSF-1R), with CSF-1. We recently identified a novel type of monocytic cell termed follicular dendritic cell-induced monocytic cells (FDMCs), whose differentiation depended on CSF-1R signaling through the IL-34 produced from a follicular dendritic cell line, FL-Y. Here, we report the functional mechanisms of the IL-34-mediated CSF-1R signaling underlying FDMC differentiation. CRIPSR/Cas9-mediated knockout of the Il34 gene confirmed that the ability of FL-Y cells to induce FDMCs completely depends on the IL-34 expressed by FL-Y cells. Transwell culture experiments revealed that FDMC differentiation requires a signal from a membrane-anchored form of IL-34 on the FL-Y cell surface, but not from a secreted form, in a direct interaction between FDMC precursor cells and FL-Y cells. Furthermore, flow cytometric analysis using an anti-IL-34 antibody indicated that IL-34 was also expressed on the FL-Y cell surface. Thus, we explored proteins interacting with IL-34 in FL-Y cells. Mass spectrometry analysis and pulldown assay identified that IL-34 was associated with the molecular chaperone 78-kDa glucose-regulated protein (GRP78) in the plasma membrane fraction of FL-Y cells. Consistent with this finding, GRP78-heterozygous FL-Y cells expressed a lower level of IL-34 protein on their cell surface and exhibited a reduced competency to induce FDMC differentiation compared with the original FL-Y cells. These results indicated a novel GRP78-dependent localization and specific function of IL-34 in FL-Y cells related to monocytic cell differentiation.
© 2019 Ogawa et al.

Entities:  

Keywords:  CRISPR/Cas; GRP78; Western blot; cell differentiation; cell surface protein; chaperone; colony-stimulating factor-1 receptor; cytokine; follicular dendritic cell; interleukin; interleukin 34; monocyte; plasma membrane

Mesh:

Substances:

Year:  2018        PMID: 30573681      PMCID: PMC6378969          DOI: 10.1074/jbc.RA118.006226

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Syndecan-1 regulates the biological activities of interleukin-34.

Authors:  Aude I Segaliny; Regis Brion; Erwan Mortier; Mike Maillasson; Michel Cherel; Yannick Jacques; Benoît Le Goff; Dominique Heymann
Journal:  Biochim Biophys Acta       Date:  2015-02-04

Review 2.  Are follicular dendritic cells really good for nothing?

Authors:  Marie H Kosco-Vilbois
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

Review 3.  Clonal selection and learning in the antibody system.

Authors:  K Rajewsky
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

4.  Generation of autonomous activity of Ca(2+)/calmodulin-dependent protein kinase kinase β by autophosphorylation.

Authors:  Hiroshi Tokumitsu; Naoya Hatano; Tomohito Fujimoto; Saki Yurimoto; Ryoji Kobayashi
Journal:  Biochemistry       Date:  2011-08-29       Impact factor: 3.162

5.  Langerhans cells arise from monocytes in vivo.

Authors:  Florent Ginhoux; Frank Tacke; Veronique Angeli; Milena Bogunovic; Martine Loubeau; Xu-Ming Dai; E Richard Stanley; Gwendalyn J Randolph; Miriam Merad
Journal:  Nat Immunol       Date:  2006-01-29       Impact factor: 25.606

6.  Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia.

Authors:  Melanie Greter; Iva Lelios; Miriam Merad; Burkhard Becher; Pawel Pelczar; Guillaume Hoeffel; Jeremy Price; Marylene Leboeuf; Thomas M Kündig; Karl Frei; Florent Ginhoux
Journal:  Immunity       Date:  2012-11-21       Impact factor: 31.745

Review 7.  Balancing AID and DNA repair during somatic hypermutation.

Authors:  Man Liu; David G Schatz
Journal:  Trends Immunol       Date:  2009-03-18       Impact factor: 16.687

8.  Mutant loxP vectors for selectable marker recycle and conditional knock-outs.

Authors:  H Arakawa; D Lodygin; J M Buerstedde
Journal:  BMC Biotechnol       Date:  2001-09-26       Impact factor: 2.563

9.  IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential.

Authors:  Sonia Boulakirba; Anja Pfeifer; Rana Mhaidly; Sandrine Obba; Michael Goulard; Thomas Schmitt; Paul Chaintreuil; Anne Calleja; Nathan Furstoss; François Orange; Sandra Lacas-Gervais; Laurent Boyer; Sandrine Marchetti; Els Verhoeyen; Frederic Luciano; Guillaume Robert; Patrick Auberger; Arnaud Jacquel
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

10.  Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.

Authors:  Yu Rebecca Miao; Bedrich L Eckhardt; Yuan Cao; Renata Pasqualini; Pedram Argani; Wadih Arap; Robert G Ramsay; Robin L Anderson
Journal:  Clin Cancer Res       Date:  2013-03-07       Impact factor: 12.531

View more
  4 in total

Review 1.  The macrophage: a key player in the pathophysiology of peripheral neuropathies.

Authors:  Zeina Msheik; Mohamed El Massry; Amandine Rovini; Fabrice Billet; Alexis Desmoulière
Journal:  J Neuroinflammation       Date:  2022-04-16       Impact factor: 9.587

2.  Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma.

Authors:  Zhendong Wang; Jun Zhu; Tianyi Wang; Hao Zhou; Jinjie Wang; Zhanghao Huang; Haijian Zhang; Jiahai Shi
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

Review 3.  The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis.

Authors:  Javier Muñoz-Garcia; Denis Cochonneau; Stéphane Télétchéa; Emilie Moranton; Didier Lanoe; Régis Brion; Frédéric Lézot; Marie-Françoise Heymann; Dominique Heymann
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 4.  The M-CSF receptor in osteoclasts and beyond.

Authors:  Se Hwan Mun; Peter Sang Uk Park; Kyung-Hyun Park-Min
Journal:  Exp Mol Med       Date:  2020-08-17       Impact factor: 8.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.